| Francis Dipaolo, MD | |
|
611 S Carlin Springs Rd, #404, Arlington, VA 22204-1064 | |
| (703) 931-1515 | |
| Not Available |
| Full Name | Francis Dipaolo |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 611 S Carlin Springs Rd, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164485355 | NPI | - | NPPES |
| 6303285 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101048914 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Virginia Hospital Center | Arlington, VA | Hospital |
| Entity Name | Insight Vision Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033231360 PECOS PAC ID: 7113018763 Enrollment ID: O20070810000416 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
In a series of lab tests, a relatively common soil bacterium has demonstrated its ability to break down the difficult-to-remove class of pollutants called PFAS, researchers at Princeton University said.
Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).
There have been conflicting reports on health benefits and harm caused by drinking alcohol. A new study from Japanese researchers has proven that taking one drink a day for a decade or two drinks for five years can raise the risk of getting cancers by 5 percent. The study titled "Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan," was published in the latest issue of the journal Cancer.
According to a new study, people who have had near death experiences often have different arousal systems controlling the sleep-wake states than people who have never had such an experience.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Francis Dipaolo, MD 611 S Carlin Springs Rd, #404, Arlington, VA 22204-1064 Ph: (703) 931-1515 | Francis Dipaolo, MD 611 S Carlin Springs Rd, #404, Arlington, VA 22204-1064 Ph: (703) 931-1515 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.
In a series of lab tests, a relatively common soil bacterium has demonstrated its ability to break down the difficult-to-remove class of pollutants called PFAS, researchers at Princeton University said.
Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).
There have been conflicting reports on health benefits and harm caused by drinking alcohol. A new study from Japanese researchers has proven that taking one drink a day for a decade or two drinks for five years can raise the risk of getting cancers by 5 percent. The study titled "Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan," was published in the latest issue of the journal Cancer.
According to a new study, people who have had near death experiences often have different arousal systems controlling the sleep-wake states than people who have never had such an experience.
› Verified 5 days ago
Dr. Nicole Kyongnan Renaud, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1050 N Highland St, Suite 210, Arlington, VA 22201 Phone: 703-486-3991 | |
Henry Tucker Dalton, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3801 Fairfax Dr, Suite 74, Arlington, VA 22203 Phone: 703-528-3910 Fax: 703-528-4367 | |
Amy Kotecha, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3801 Fairfax Dr, Suite 74, Arlington, VA 22203 Phone: 703-528-3910 Fax: 703-528-4367 | |
Walter Q Wang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 208, Arlington, VA 22204 Phone: 703-639-4455 Fax: 703-462-8331 | |
Maurice Leonard Gaspar, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1635 N. George Mason Dr., Suite 100, Arlington, VA 22205 Phone: 703-524-5777 Fax: 703-908-9647 | |
Dr. Namtran H Pham, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3801 N Fairfax Drive, Ste 74, Arlington, VA 22203 Phone: 703-528-3910 Fax: 703-528-4367 |